News Center

Actual patient. Results may vary. Actual patient. Results may vary.
Follow Us @AllerganAesthetics

Fourth Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day Most Successful One Yet

<p>A RECORD-BREAKING NUMBER OF CONSUMERS PARTICIPATED, WITH BOGO GIFT CARDS SELLING OUT IN JUST A FEW HOURS11 IRVINE, Calif., Nov. 17, 2022 /PRNewswire/ -- Yesterday, Allergan Aesthetics, an AbbVie...</p> …

Allergan Aesthetics Reaffirms Commitment to Breast Health Advocacy with Yearlong Program for Breast Cancer Awareness

<p>PINK RIBBON STRONG 365 IS DEDICATED TO PROVIDING EDUCATIONAL INITIATIVES AND SHARING REAL STORIES TO SUPPORT PATIENTS, SURVIVORS, AND PREVIVORS IRVINE, Calif., Nov. 3, 2022 /PRNewswire/ --...</p> …

Allergan Aesthetics Celebrates Fourth Annual BOTOX® Cosmetic (onabotulinumtoxinA) Day

<p>THE ICONIC BRAND ENCOURAGES PEOPLE TO TAKE A 'MOMENT FOR YOU' WITH TWO EXCLUSIVE OFFERS FOR FAMILY AND FRIENDS, POWERED BY ALLĒ IRVINE, Calif., Nov. 2, 2022 /PRNewswire/ -- Allergan Aesthetics,...</p> …

Allergan Aesthetics and Girls Inc. Partner to Bridge the Gender Gap in STEM

<p>-- A social media campaign kicks off in November with the goal of educating on the lack of female, diverse representation in STEM and raising up to $250,000 for Girls Inc. -- Girls from Girls Inc....</p> …

Allergan Aesthetics to Present Data from Its Leading Aesthetic Portfolio at the 2022 American Society for Dermatologic Surgery Meeting

<p>–Data results shared across facial injectables, body contouring and skincare portfolio highlights Allergan Aesthetics' continued commitment to advancing aesthetic medicine –Analyses of 15...</p> …

The Forces of Beauty® Report from The DREAM Initiative® Reveals Demand for New Standards of Beauty and Imagery

<p>--Initiative Creates Groundbreaking New, Royalty Free Inclusive Image Gallery In Strategic Partnership with Shutterstock Studios-- IRVINE, Calif. and PHOENIX, Sept. 22, 2022 /PRNewswire/ -- Today,...</p> …

Allergan Aesthetics and BOTOX® Cosmetic (OnabotulinumtoxinA) Reveal New 'See Yourself' Campaign Cast, Spotlighting 25 Real People and Their Stories

<p>NEARLY 20,000 PEOPLE RESPONDED TO AN OPEN CASTING CALL FOR A CHANCE TO BE FEATURED IN THE UPCOMING CAMPAIGN FOR THE NUMBER ONE SELLING PRODUCT OF ITS KIND IRVINE, Calif., Sept. 13, 2022...</p> …

Allergan Aesthetics Celebrates 100 Million Syringes of JUVÉDERM®

<p>JUVÉDERM® Collection of Fillers Continues Position as the World's Number One Chosen Dermal Filler Collection IRVINE, Calif., Sept. 7, 2022 /PRNewswire/ -- Today, Allergan Aesthetics, an AbbVie...</p> …

SkinMedica® Launches Firm & Tone Lotion for Body

<p>Powerful, Effective, Targeted Topical Treatment Formulated to Prevent and Address Visible Signs of Body Skin Aging IRVINE, Calif., Aug. 31, 2022 /PRNewswire/ -- Today, Allergan Aesthetics, an...</p> …

Allergan Aesthetics publishes 'The Future of Aesthetics' global trends report

<p>-- Report is aimed at helping practitioners and the industry prepare for the future by supporting the evolving needs of patients -- -- North American medical aesthetic market expected to grow more</p> …

Experience the JUVÉDERM® Difference with Allergan Aesthetics

<p>Allē Double Point Promotion Encourages Consumers to See the JUVÉDERM® Difference IRVINE, Calif., Aug. 17, 2022 /PRNewswire/ -- Allergan Aesthetics, an AbbVie company (NYSE: ABBV), invites...</p> …

FDA Approves JUVÉDERM® VOLUX™ XC for Improvement of Jawline Definition

<p>JUVÉDERM® VOLUX™ XC IS THE FIRST AND ONLY HYALURONIC ACID (HA) FILLER TO RECEIVE U.S. FDA APPROVAL FOR IMPROVING JAWLINE DEFINITION IRVINE, Calif., Aug. 3, 2022 /PRNewswire/ -- Today, Allergan...</p> …

AbbVie and Allergan Aesthetics to Present New Data from Leading Neurotoxin Portfolio at TOXINS 2022 Conference

<p>– Data analyses of onabotulinumtoxinA (BOTOX®) in adult patients with chronic migraine, cervical dystonia, overactive bladder, spasticity, and pediatric patients with neurogenic detrusor...</p> …

Allergan Aesthetics publishes 'The Future of Aesthetics' global trends report providing unrivalled insight into future of industry

<p>-- Report is aimed at helping practitioners and the industry understand and prepare for the future by supporting the evolving needs of patients -- -- Built on robust market research and analysis...</p> …

BOTOX® Cosmetic (onabotulinumtoxinA) Celebrates 20 Years Since First U.S. FDA Approval

<p>Iconic Brand Was The First Product Of Its Kind To Receive U.S. Food And Drug Administration Approval In 2002 For Aesthetic Use And Is Honoring This Milestone By Celebrating Its Loyal Patients And...</p> …

ALLERGAN AESTHETICS BRINGS DATA, INNOVATION & INDUSTRY EXPERTISE TO THE 2022 AESTHETIC AND ANTI-AGING MEDICINE WORLD CONGRESS (AMWC)

<p>-Industry leader demonstrates commitment to the future of aesthetics with forward-facing, trends report- -Meeting will signify the launch of HArmonyCa™, hybrid injectable across Europe and in...</p> …

AbbVie and Allergan Aesthetics to Present New Research Across Dermatology Portfolio at 2022 AAD Annual Meeting

<p>Twelve abstracts and two late-breaking presentations demonstrate AbbVie and Allergan Aesthetics' shared commitment to advancing research across a spectrum of dermatologic conditions and aesthetic...</p> …

FDA Approves JUVÉDERM® VOLBELLA® XC For Undereye Hollows

<p>Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the FDA approval of JUVÉDERM® VOLBELLA® XC for improvement of infraorbital hollows in adults over the age of 21.2 According to...</p> …

Allergan Aesthetics Announces Open Casting Call for BOTOX® Cosmetic (onabotulinumtoxinA)

<p>Allergan Aesthetics, an AbbVie company (NYSE: ABBV) announced today it will be hosting an open casting call seeking people who would like to share their BOTOX® Cosmetic Story. The company...</p> …

Allergan Aesthetics Completes Acquisition of Soliton

<p>Allergan Aesthetics, an AbbVie company (NYSE: ABBV), today announced the successful completion of its acquisition of Soliton, Inc. (NASDAQ: SOLY). The addition of Soliton and its technology...</p> …

Allergan Aesthetics To Present Data From Its Leading Aesthetic Portfolio At The 2021 American Society For Dermatologic Surgery Virtual Meeting

<p>Allergan Aesthetics, an AbbVie company, (NYSE: ABBV) today announced that it will present six abstracts from its leading portfolio of aesthetic treatments and products at the American Society for...</p> …

Allergan Aesthetics Celebrates Third Annual BOTOX® Cosmetic (onabotulinumtoxina) Day

<p>Let the countdown begin. Experience the interactive Multichannel News Release here: https://www.multivu.com/players/English/8966951-allergan-aesthetics-alle-botox-cosmetic-day/ Allergan...</p> …

Allergan Aesthetics Launches Series of Initiatives to Support Breast Cancer Awareness

<p>Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is continuing its commitment to breast health, awareness, restoration, and research in support of breast cancer awareness month. For the month...</p> …

DREAM™ Initiative Releases, The Full Spectrum of Dermatology: A Diverse and Inclusive Atlas

Allergan Aesthetics, an AbbVie company, and SkinBetter Science through their DREAMTM (Driving Racial Equity in Aesthetic Medicine) initiative are supporting the development and distribution of The …

Allergan Aesthetics Continues Partnership with Girls Inc. to Empower Confidence in High School-Aged Girls Interested in STEM

Today Allergan Aesthetics, now an AbbVie company, announces its third consecutive year of partnership with Girls Inc. and debut of its Empowering Confidence Workshops, a nationwide mentoring …

Allergan Aesthetics and BOTOX® Cosmetic (onabotulinumtoxinA) Put Real Stories at the Forefront in New Campaign

Allergan Aesthetics, an AbbVie company (NYSE: ABBV), is changing the way BOTOX® Cosmetic, the #1 selling neurotoxin treatment1, is connecting with consumers. Today, the brand is launching 'See …

Allergan Aesthetics to Acquire Soliton, Expanding Body Contouring Portfolio

Allergan Aesthetics, an AbbVie company (NYSE: ABBV) and Soliton (NASDAQ: SOLY) today announced a definitive agreement under which Allergan Aesthetics will acquire Soliton and RESONICTM, its Rapid …

SkinMedica® Launches Neck Correct Cream for Neck and Décolleté

Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announces the launch of SkinMedica® Neck Correct Cream, the first product from the professional-grade skincare line formulated to …

CoolSculpting® by Allergan Aesthetics Expands Body Contouring Portfolio With CoolSculpting® Elite

Today, Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced the launch of CoolSculpting® Elite, its next generation fat reduction system with applicators designed to complement the …

Allergan Aesthetics and Allergan, an AbbVie Company, to Present 16 Neurotoxin Research Abstracts Across Multiple Therapeutic and Cosmetic Indications at the TOXINS 2021 Virtual Conference

Allergan Aesthetics and Allergan, an AbbVie company (NYSE: ABBV), announced today that scientific and clinical experts in the field of neurotoxins will present results from 16 abstracts spanning …

Allergan Aesthetics Enters Into Option to Acquire Cypris Medical

Today Allergan Aesthetics, an AbbVie company (NYSE: ABBV), announced that it has entered into a warrant agreement with Cypris Medical, a privately held, medical device company based in Chicago …